Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity.
Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
Published: July 13, 2022
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.
Journal: Ophthalmology
Published: February 22, 2022
Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial.
Journal: Journal of perinatology : official journal of the California Perinatal Association
Published: November 19, 2020
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity.
Journal: JAMA ophthalmology
Published: April 24, 2020
Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria.
Journal: JAMA ophthalmology
Published: November 15, 2019
Treatment of non-type 1 retinopathy of prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study.
Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
Published: June 02, 2019
Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.
Journal: JAMA
Published: October 26, 2018
Reply.
Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
Published: October 19, 2018
Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients.
Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
Published: October 02, 2017
Last Updated: 09/26/2026